These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 39009078

  • 1. The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review.
    Ezhumalai B, Modi R, Panchanatham M, Kaliyamoorthy D.
    Indian Heart J; 2024; 76(4):229-239. PubMed ID: 39009078
    [Abstract] [Full Text] [Related]

  • 2. Sodium-Glucose Cotransporter 2 Inhibitors First Strategy Improve Decongestion in Patients with Symptomatic Heart Failure and Reduced Ejection Fraction When Compared to Angiotensin Receptor Neprilysin Inhibitor First Strategy.
    Lee WC, Chang WT, Hong CS, Liao CT, Huang PS, Huang SC, Lin CH, Chiang CY, Chen ZC, Shih JY.
    Front Biosci (Landmark Ed); 2023 Apr 27; 28(4):81. PubMed ID: 37114551
    [Abstract] [Full Text] [Related]

  • 3. Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020.
    Karlström P, Pivodic A, Dahlström U, Fu M.
    Clin Res Cardiol; 2024 Sep 27; 113(9):1355-1368. PubMed ID: 39186181
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Systematic Review and Network Meta-Analysis.
    Zafeiropoulos S, Farmakis IT, Milioglou I, Doundoulakis I, Gorodeski EZ, Konstantinides SV, Cooper L, Zanos S, Stavrakis S, Giamouzis G, Butler J, Giannakoulas G.
    JACC Heart Fail; 2024 Apr 27; 12(4):616-627. PubMed ID: 37656079
    [Abstract] [Full Text] [Related]

  • 5. The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure.
    Ji PJ, Zhang ZY, Yan Q, Cao HL, Zhao YJ, Yang B, Li J.
    ESC Heart Fail; 2023 Apr 27; 10(2):1314-1325. PubMed ID: 36722326
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
    Srivastava PK, Claggett BL, Solomon SD, McMurray JJV, Packer M, Zile MR, Desai AS, Rouleau JL, Swedberg K, Fonarow GC.
    JAMA Cardiol; 2018 Dec 01; 3(12):1226-1231. PubMed ID: 30484837
    [Abstract] [Full Text] [Related]

  • 10. Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction.
    Schupp T, Bertsch T, Reinhardt M, Abel N, Schmitt A, Lau F, Abumayyaleh M, Akin M, Weiß C, Weidner K, Behnes M, Akin I.
    Eur J Prev Cardiol; 2024 Aug 22; 31(11):1347-1360. PubMed ID: 38513366
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?
    Abdelhamid M, Rosano G, Metra M, Adamopoulos S, Böhm M, Chioncel O, Filippatos G, Jankowska EA, Lopatin Y, Lund L, Milicic D, Moura B, Ben Gal T, Ristic A, Rakisheva A, Savarese G, Mullens W, Piepoli M, Bayes-Genis A, Thum T, Anker SD, Seferovic P, Coats AJS.
    Eur J Heart Fail; 2022 Sep 22; 24(9):1460-1466. PubMed ID: 35753058
    [Abstract] [Full Text] [Related]

  • 13. Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction.
    Kim HM, Hwang IC, Choi W, Yoon YE, Cho GY.
    Sci Rep; 2021 Nov 16; 11(1):22342. PubMed ID: 34785723
    [Abstract] [Full Text] [Related]

  • 14. Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study.
    Hsiao FC, Lin CP, Tung YC, Chang PC, McMurray JJV, Chu PH.
    Int J Cardiol; 2021 May 01; 330():91-97. PubMed ID: 33587940
    [Abstract] [Full Text] [Related]

  • 15. Unlocking the Potential: Angiotensin Receptor Neprilysin and Sodium Glucose Co-Transporter 2 Inhibitors for Right Ventricle Dysfunction in Heart Failure.
    Das BB.
    Medicina (Kaunas); 2024 Jul 09; 60(7):. PubMed ID: 39064541
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study.
    Quiroga B, Ortiz A, Núñez S, Kislikova M, González Sanchidrián S, Broseta JJ, Albines ZS, Escamilla Cabrera B, Rivero Viera Y, Rodriguez Santarelli D, Salanova Villanueva L, Lopez Rodriguez F, Cancho Castellano B, Ibáñez Cerezon M, Gutierrez Rivas CP, Aresté N, Campos Gutiérrez B, Ródenas Gálvez A, Glucksmann Pizá MC, Balda Manzanos S, Soldevila A, Rodríguez Gayo L, Moral Berrio E, Ortega Diaz M, Beltrán Catalán S, Puente García A, Ángel Rojas M, Sosa Barrios RH, Santana Zapatero H, Rangel Hidalgo G, Martinez Canet AM, Díez J, Cardiorenal Medicine Group (CaReSEN) of the Spanish Society of Nephrology.
    Cardiorenal Med; 2024 Jul 09; 14(1):202-214. PubMed ID: 38513622
    [Abstract] [Full Text] [Related]

  • 17. The ability of modern therapy to improve the prognosis of patients with HF: role of angiotensin neprilysin inhibitors and sodium-glucose cotransporter inhibitors.
    Mareev YV, Mareev VY.
    Kardiologiia; 2021 Jul 01; 61(6):4-10. PubMed ID: 34311683
    [Abstract] [Full Text] [Related]

  • 18. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
    Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, Brueckmann M, Ofstad AP, Pfarr E, Jamal W, Packer M.
    Lancet; 2020 Sep 19; 396(10254):819-829. PubMed ID: 32877652
    [Abstract] [Full Text] [Related]

  • 19. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction.
    Tromp J, Ouwerkerk W, van Veldhuisen DJ, Hillege HL, Richards AM, van der Meer P, Anand IS, Lam CSP, Voors AA.
    JACC Heart Fail; 2022 Feb 19; 10(2):73-84. PubMed ID: 34895860
    [Abstract] [Full Text] [Related]

  • 20. Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States.
    Yan BW, Spahillari A, Pandya A.
    Circ Cardiovasc Qual Outcomes; 2023 Jun 19; 16(6):e009793. PubMed ID: 37278232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.